The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Imaging metastatic prostate cancer with 18F-DCFBC PET/CT (DCFBC) and 18F-NaF PET/CT (NaF).
 
Farhad Fakhrejahani
No Relationships to Disclose
 
Maria Liza Lindenberg
No Relationships to Disclose
 
Ethan S. Bargvall
No Relationships to Disclose
 
Esther Mena
No Relationships to Disclose
 
Baris Turkbey
No Relationships to Disclose
 
Stephen Adler
No Relationships to Disclose
 
James L. Gulley
Consulting or Advisory Role - TRM Oncology
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Martin G. Pomper
Leadership - Cancer Targeting Systems
Stock and Other Ownership Interests - Cancer Targeting Systems
Consulting or Advisory Role - Cancer Targeting Systems
Research Funding - Cancer Targeting Systems; Cancer Targeting Systems (Inst); Juno Therapeutics; Juno Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Intuitive Surgical; Intuitive Surgical (Inst); Progenies Pharma; Progenies Pharma (Inst)
Travel, Accommodations, Expenses - Cancer Targeting Systems
 
William L. Dahut
No Relationships to Disclose
 
Peter L. Choyke
Patents, Royalties, Other Intellectual Property - I am a patent holder for MRI-Ultrasound fusion technology licensed to InVivo which markets it as UroNav. However, as a government employee I personally receive no financial benefit from this patent.